- Home
- AKRO vs AGM Comparison
AKRO vs AGM Comparison
Compare AKRO & AGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- AGM
- Stock Information
- Founded
- AKRO 2017
- AGM 1987
- Country
- AKRO United States
- AGM United States
- Employees
- AKRO N/A
- AGM N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- AGM Finance Companies
- Sector
- AKRO Health Care
- AGM Finance
- Exchange
- AKRO Nasdaq
- AGM Nasdaq
- Market Cap
- AKRO 3.9B
- AGM 2.1B
- IPO Year
- AKRO 2019
- AGM N/A
- Fundamental
- Price
- AKRO $51.77
- AGM $201.02
- Analyst Decision
- AKRO Strong Buy
- AGM Hold
- Analyst Count
- AKRO 6
- AGM 1
- Target Price
- AKRO $82.50
- AGM $215.00
- AVG Volume (30 Days)
- AKRO 1.7M
- AGM 201.5K
- Earning Date
- AKRO 08-08-2025
- AGM 08-04-2025
- Dividend Yield
- AKRO N/A
- AGM 2.98%
- EPS Growth
- AKRO N/A
- AGM N/A
- EPS
- AKRO N/A
- AGM 16.17
- Revenue
- AKRO N/A
- AGM $357,515,000.00
- Revenue This Year
- AKRO N/A
- AGM $9.70
- Revenue Next Year
- AKRO N/A
- AGM $8.26
- P/E Ratio
- AKRO N/A
- AGM $12.43
- Revenue Growth
- AKRO N/A
- AGM N/A
- 52 Week Low
- AKRO $21.02
- AGM $159.64
- 52 Week High
- AKRO $58.40
- AGM $217.60
- Technical
- Relative Strength Index (RSI)
- AKRO 49.14
- AGM 63.29
- Support Level
- AKRO $51.08
- AGM $192.83
- Resistance Level
- AKRO $57.35
- AGM $199.75
- Average True Range (ATR)
- AKRO 2.21
- AGM 4.27
- MACD
- AKRO -0.81
- AGM 0.74
- Stochastic Oscillator
- AKRO 11.08
- AGM 93.68
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About AGM Federal Agricultural Mortgage Corporation
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.